UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 230

Sortiert nach

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2014-03, Vol.66 (3), p.513-522

2014

Volltextzugriff (PDF)

An add-on training program involving breathing exercises, cold exposure, and meditation attenuates inflammation and disease activity in axial spondyloarthritis - A proof of concept trial

PloS one, 2019-12, Vol.14 (12), p.e0225749-e0225749

2019

Volltextzugriff (PDF)

Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2012-05, Vol.64 (5), p.1323-1328

2012

Volltextzugriff (PDF)

Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase

Annals of the rheumatic diseases, 2011-05, Vol.70 (5), p.772-777

2011

Volltextzugriff (PDF)

Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort

Arthritis research & therapy, 2021-08, Vol.23 (1), p.210-210, Article 210

2021

Volltextzugriff (PDF)

Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort

Arthritis research & therapy, 2021-10, Vol.23 (1), p.263-263, Article 263

2021

Volltextzugriff (PDF)

Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial

Osteoporosis international, 2021-07, Vol.32 (7), p.1441-1449

2021

Volltextzugriff (PDF)

Dyslipidaemia in patients with seropositive arthralgia predicts the development of arthritis

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1915-1916

2012

Volltextzugriff (PDF)

Temporomandibular joint function, periodontal health, and oral microbiome in early rheumatoid arthritis and at-risk individuals: a prospective cohort study protocol

BDJ open, 2020, Vol.6 (1), p.7-7, Article 7

2020

Volltextzugriff (PDF)

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis

Rheumatic & musculoskeletal diseases open, 2020-07, Vol.6 (2), p.e001163

2020

Volltextzugriff (PDF)

SP0102 What Symptoms do GPS See and what do they do?

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.26-26

van Schaardenburg, D.

2015

Volltextzugriff (PDF)

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept

Annals of the rheumatic diseases, 2011-02, Vol.70 (2), p.284-288

2011

Volltextzugriff (PDF)

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.490-494

2010

Volltextzugriff (PDF)

The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development

Scandinavian journal of rheumatology, 2023-09, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Volltextzugriff (PDF)

Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria

Annals of the rheumatic diseases, 2011-08, Vol.70 (8), p.1468-1470

2011

Volltextzugriff (PDF)

Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2009-04, Vol.68 (4), p.558-563

2009

Volltextzugriff (PDF)

Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity

Seminars in arthritis and rheumatism, 2021-12, Vol.51 (6), p.1360-1369

2021

Volltextzugriff (PDF)

Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.571-574

2010

Volltextzugriff (PDF)

Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning

Scandinavian journal of rheumatology, 2023-11, Vol.ahead-of-print (ahead-of-print), p.1-9

2023

Volltextzugriff (PDF)

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

Annals of the rheumatic diseases, 2011-08, Vol.70 (8), p.1389-1394

2011

Volltextzugriff (PDF)

Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study

Arthritis & rheumatology (Hoboken, N.J.), 2011-04, Vol.63 (4), p.877-883

2011

Volltextzugriff (PDF)

THU0045 14-3-3eta Positivity Is Associated with Radiographic Progression despite Patients Achieving Clinical Remission

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.193-194

2016

Volltextzugriff (PDF)

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.184-188

2007

Volltextzugriff (PDF)

Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme

Scandinavian journal of rheumatology, 2019-09, Vol.48 (5), p.345-352

2019

Volltextzugriff (PDF)

DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis

Annals of the rheumatic diseases, 2010-01, Vol.69 (1), p.65-69

2010

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(226)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Humans
(129)
Life Sciences & Biomedicine
(129)
Rheumatology
(114)
Male
(102)
Female
(96)
Middle Aged
(91)
Biological And Medical Sciences
(65)
Medical Sciences
(64)
Rheumatoid Arthritis
(64)
Adult
(63)
Aged
(59)
Diseases Of The Osteoarticular System
(50)
Inflammatory Joint Diseases
(35)
Arthritis, Rheumatoid - Immunology
(33)
Arthritis, Rheumatoid - Drug Therapy
(29)
Antirheumatic Agents - Therapeutic Use
(26)
Aged, 80 And Over
(23)
Patients
(23)
Disease Progression
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis: Implications for Understanding Preclinical Rheumatoid Arthritis

An add-on training program involving breathing exercises, cold exposure, and meditation attenuates inflammation and disease activity in axial spondyloarthritis - A proof of concept trial

Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis

Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase

Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort

Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort

Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial

Dyslipidaemia in patients with seropositive arthralgia predicts the development of arthritis

Temporomandibular joint function, periodontal health, and oral microbiome in early rheumatoid arthritis and at-risk individuals: a prospective cohort study protocol

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis

SP0102 What Symptoms do GPS See and what do they do?

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study

The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development

Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria

Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis

Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity

Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study

THU0045 14-3-3eta Positivity Is Associated with Radiographic Progression despite Patients Achieving Clinical Remission

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme

DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis

Suchergebnisse filtern